[artículo] 
inThe Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.8 (Agosto) . - pp.1075-1084

Título :	Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial
Tipo de documento:	texto impreso
Autores:	Christopher Pittenger, Autor ; Michael H. Bloch, Autor ; Suzanne Wasylink, Autor
Fecha de publicación:	2020
Artículo en la página:	pp.1075-1084
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Terapia farmacológica, Antagonistas de aminoácidos excitatorios, Trastorno obsesivo-compulsivo, Riluzol, Inhibidores de la captación de serotonina.
Resumen:	Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms.
Link:	./index.php?lvl=notice_display&id=21870

[artículo] Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial [texto impreso] / Christopher Pittenger, Autor ; Michael H. Bloch, Autor ; Suzanne Wasylink, Autor . - 2020 . - pp.1075-1084.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.8 (Agosto) . - pp.1075-1084

Palabras clave:	Terapia farmacológica, Antagonistas de aminoácidos excitatorios, Trastorno obsesivo-compulsivo, Riluzol, Inhibidores de la captación de serotonina.
Resumen:	Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms.
Link:	./index.php?lvl=notice_display&id=21870